tradingkey.logo

tradingkey.logo
怜玢


Zhongchao Inc

ZCMD
りォッチリストに远加
1.460USD
+0.030+2.07%
終倀 05/15, 16:00ET15分遅れの株䟡
5.63M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Zhongchao Inc 䌁業名

Zhongchao Inc is a holding company engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public in China. The Company operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.

Zhongchao Incの䌁業情報


䌁業コヌドZCMD
䌚瀟名Zhongchao Inc
䞊堎日Feb 19, 2020
最高経営責任者「CEO」Yang (Weiguang)
埓業員数111
蚌刞皮類Ordinary Share
決算期末Feb 19
本瀟所圚地841 Yan An Middle Road, Jing An District
郜垂SHANGHAI
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜China
郵䟿番号200040
電話番号862132205987
りェブサむトhttps://www.mdmooc.org/
䌁業コヌドZCMD
䞊堎日Feb 19, 2020
最高経営責任者「CEO」Yang (Weiguang)

Zhongchao Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Weiguang Yang
Mr. Weiguang Yang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
8.59K
-699.98%
Ms. Pei Xu
Ms. Pei Xu
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
458.00
--
Dan Li
Dan Li
Independent Director
Independent Director
241.00
-698.76%
Mr. Xuejun Chen
Mr. Xuejun Chen
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Baoqian Tian
Mr. Baoqian Tian
Chief Sales Officer
Chief Sales Officer
--
--
Ms. Shuang Wu
Ms. Shuang Wu
Chief Operating Officer
Chief Operating Officer
--
--
John General
John General
Independent Director
Independent Director
--
--
Mr. Kevin D. Vassily
Mr. Kevin D. Vassily
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Weiguang Yang
Mr. Weiguang Yang
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
8.59K
-699.98%
Ms. Pei Xu
Ms. Pei Xu
Chief Financial Officer, Company Secretary, Director
Chief Financial Officer, Company Secretary, Director
458.00
--
Dan Li
Dan Li
Independent Director
Independent Director
241.00
-698.76%
Mr. Xuejun Chen
Mr. Xuejun Chen
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Baoqian Tian
Mr. Baoqian Tian
Chief Sales Officer
Chief Sales Officer
--
--
Ms. Shuang Wu
Ms. Shuang Wu
Chief Operating Officer
Chief Operating Officer
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Apr 6
通貚: USD曎新時刻: Mon, Apr 6
FY2024
FY2023
FY2022
事業別USD
䌚瀟名
収益
比率
Medical training and education services
7.70M
48.57%
Patiend management services in patient aid projects
5.91M
37.25%
Sales of patented drugs
2.15M
13.56%
Other revenues
97.78K
0.62%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Medical training and education services
7.70M
48.57%
Patiend management services in patient aid projects
5.91M
37.25%
Sales of patented drugs
2.15M
13.56%
Other revenues
97.78K
0.62%

株䞻

曎新時刻: Wed, May 13
曎新時刻: Wed, May 13
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Yang (Weiguang)
0.27%
Citadel Advisors LLC
0.13%
Worthy Health Limited Partnership
0.12%
Susquehanna International Group, LLP
0.08%
Two Sigma Investments, LP
0.07%
他の
99.33%
株䞻統蚈
株䞻統蚈
比率
Yang (Weiguang)
0.27%
Citadel Advisors LLC
0.13%
Worthy Health Limited Partnership
0.12%
Susquehanna International Group, LLP
0.08%
Two Sigma Investments, LP
0.07%
他の
99.33%
皮類
株䞻統蚈
比率
Individual Investor
0.30%
Hedge Fund
0.20%
Corporation
0.12%
Investment Advisor
0.08%
Venture Capital
0.04%
他の
99.25%

機関投資家保有株


曎新時刻: Wed, Apr 1
曎新時刻: Wed, Apr 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2026Q4
5
46.53K
0.35%
--
2026Q1
9
10.45K
0.32%
+1.43K
2025Q4
10
19.22K
0.07%
-91.25K
2025Q3
9
76.31K
0.31%
+27.32K
2025Q2
16
6.21M
25.01%
+5.90M
2025Q1
16
6.21M
25.01%
+5.90M
2024Q4
12
290.74K
5.74%
+8.25K
2024Q3
12
266.95K
5.35%
-114.71K
2024Q2
13
300.94K
7.08%
-44.59K
2024Q1
14
279.19K
6.00%
-52.36K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Yang (Weiguang)
68.75K
2.14%
+68.75K
--
Aug 25, 2025
Citadel Advisors LLC
4.21K
0.13%
+1.89K
+81.78%
Dec 31, 2025
Worthy Health Limited Partnership
32.12K
1%
--
--
Dec 31, 2024
Susquehanna International Group, LLP
2.54K
0.08%
+2.54K
--
Dec 31, 2025
Two Sigma Investments, LP
2.32K
0.07%
+2.32K
--
Dec 31, 2025
XTX Markets LLC
1.39K
0.04%
+1.39K
--
Dec 31, 2025
Li (Dan)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
General (John C)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
Vassily (Kevin)
1.93K
0.06%
+1.63K
+541.67%
Dec 31, 2024
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Feb 26, 2026
Merger
8→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
日付
配圓萜ち日
皮類
比率
Feb 26, 2026
Merger
8→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
Feb 27, 2024
Merger
10→1
KeyAI
î™